What are the vasoconstrictor effects of arginine vasopressin (AVP) in patients with diabetes insipidus (DI)?

Updated: Mar 18, 2020
  • Author: Romesh Khardori, MD, PhD, FACP; Chief Editor: George T Griffing, MD  more...
  • Print

The vasoconstrictor effect of AVP is negligible in humans. No clinically significant defects in blood pressure regulation or cortisol secretion are apparent in patients with DI.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!